BerGenBio ASA Cash Flow Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Net Income	-139.28	-190.4	-302.12	-309.36	-257.03	Upgrade
Depreciation & Amortization	0.46	0.22	0.88	1.31	0.73	Upgrade
Stock-Based Compensation	5.71	3.14	3.47	7.11	7.41	Upgrade
Other Operating Activities	-8.49	-4.63	-0.64	-7.5	1.03	Upgrade
Change in Accounts Receivable	2.93	-1.62	-3.46	1.83	1.59	Upgrade
Change in Accounts Payable	-14.56	-31.81	13.64	3.27	11.98	Upgrade
Operating Cash Flow	-153.24	-225.1	-288.23	-303.34	-234.29	Upgrade
Capital Expenditures	-	-	-	-	-0.07	Upgrade
Sale of Property, Plant & Equipment	0.17	-	0.3	-	-	Upgrade
Other Investing Activities	3.52	3.06	2.95	3.13	3.62	Upgrade
Investing Cash Flow	3.69	3.06	3.25	3.13	3.55	Upgrade
Long-Term Debt Repaid	-0.44	-0.19	-0.31	-0.57	-0.59	Upgrade
Net Debt Issued (Repaid)	-0.44	-0.19	-0.31	-0.57	-0.59	Upgrade
Issuance of Common Stock	138.87	262.05	3.22	16.63	740.85	Upgrade
Other Financing Activities	-8.83	-36.97	-0.01	-0.07	-40.76	Upgrade
Financing Cash Flow	129.61	224.88	2.9	16	699.51	Upgrade
Foreign Exchange Rate Adjustments	3.68	2.78	-3.76	-0.78	-0.71	Upgrade
Miscellaneous Cash Flow Adjustments	0	-	-	-0	-	Upgrade
Net Cash Flow	-16.27	5.62	-285.84	-285	468.06	Upgrade
Free Cash Flow	-153.24	-225.1	-288.23	-303.34	-234.36	Upgrade
Free Cash Flow Margin	-18070.99%	-63587.85%	-74095.37%	-39191.21%	-38994.51%	Upgrade
Free Cash Flow Per Share	-4.34	-15.73	-325.18	-344.88	-312.81	Upgrade
Levered Free Cash Flow	-99.87	-150.01	-176.59	-188.09	-137.63	Upgrade
Unlevered Free Cash Flow	-99.87	-149.64	-176.39	-188.05	-137.61	Upgrade
Change in Net Working Capital	11.51	33.12	-10.29	-0.06	-17.51	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.